◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Xenetic Biosciences, Inc.

CIK: 1534525 SIC: 2834
$2.98M
Revenue
$-2.68M
Net Income
-
Gross Margin
-95.23%
Op. Margin
$-4.67M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 14 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $2.98M $2.98M $2.50M $2.54M $1.71M $1.16M
Revenue Growth % 0.0% 19.0% -1.6% 48.8% 47.1% nan%
Operating Expenses $5.81M $5.81M $6.70M $7.06M $8.42M $6.91M
Research & Development $3.07M $3.07M $3.29M $3.49M $4.77M $3.16M
+ Operating Income $-2.83M $-2.83M $-4.20M $-4.52M $-6.72M $-5.75M
Operating Margin % -95.2% -95.2% -168.2% -177.8% -393.6% -495.1%
Interest Expense - - - - - -
Other Income/Expense $5.72K $5.72K $-5.71K $25.38K $-1.60K $1.12K
Income Tax Expense - - - - - -
+ Net Income $-2.68M $-2.68M $-3.96M $-4.13M $-6.55M $-5.65M
Net Margin % -90.1% -90.1% -158.4% -162.8% -383.9% -486.4%
Basic EPS nan -1.58 -2.57 -2.71 -4.61 nan
Diluted EPS nan -1.58 -2.57 -2.71 -4.61 nan
Basic Shares Outstanding 159K 1.7M 1.5M 1.5M 14.2M 10.3M
Diluted Shares Outstanding 159K 1.7M 1.5M 1.5M 14.2M 10.3M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents - $6.17M $8.98M $13.10M $18.24M
Other Current Assets $166.29K $421.95K $603.83K $556.09K $479.40K
Total Current Assets $8.05M $6.59M $9.59M $13.65M $18.72M
Other Non-current Assets $313.92K $313.92K $1.02M $1.07M $1.09M
Total Assets $8.36M $6.90M $10.61M $14.72M $19.82M
Accounts Payable $258.11K $283.62K $240.83K $287.36K $362.47K
Accrued Liabilities $709.92K $610.65K - - -
Total Current Liabilities $968.02K $894.26K $809.59K $1.07M $1.42M
Total Liabilities $968.02K $894.26K $809.59K $1.07M $1.42M
Common Stock $2.29K $1.54K $1.54K $15.19K $13.46K
Retained Earnings $-199.88M $-197.19M $-193.23M $-189.10M $-182.55M
Treasury Stock - - - $5.28M $5.28M
Total Stockholders Equity $7.40M $6.01M $9.80M $13.65M $18.39M
Total Liabilities & Equity $8.36M $6.90M $10.61M $14.72M $19.82M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-2.68M $-2.68M $-3.96M $-4.13M $-6.55M $-5.65M
Stock-based Compensation - $64.79K $171.81K - - $410.44K
Operating Cash Flow $-4.67M $-2.29M $-2.82M $-4.11M $-4.65M $-4.74M
Investing Cash Flow - - - - $-500.00K -
Stock Issued - $4.00M - - - $11.45M
Financing Cash Flow - $4.00M - - - $11.45M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $1.03M $614.24K $2.21M $1.85M
Operating Expenses $1.57M $1.11M $4.42M $4.96M
Research & Development $756.48K $367.99K $2.29M $2.25M
Operating Income $-544.73K $-499.47K $-2.21M $-3.11M
Interest Expense - - - -
Other Income/Expense $4.01K $1.50K $5.57K $1.53K
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Basic EPS -0.33 -0.28 -1.36 -1.89
Diluted EPS -0.33 -0.28 -1.36 -1.89
Basic Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Diluted Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Other Current Assets $946.36K $421.95K
Total Current Assets $5.07M $6.59M
Other Non-current Assets - $313.92K
Total Assets $5.07M $6.90M
Accounts Payable $578.25K $283.62K
Total Current Liabilities $1.11M $894.26K
Total Liabilities $1.11M $894.26K
Common Stock $1.54K $1.54K
Retained Earnings $-199.30M $-197.19M
Total Stockholders Equity $3.96M $6.01M
Total Liabilities & Equity $5.07M $6.90M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Operating Cash Flow - - $-2.04M $-2.14M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...